Hjem › Leverkreft › Washington › Seattle
Kliniske studier for Leverkreft i Seattle, WA
5 studier for Leverkreft søker deltakere på steder i og rundt Seattle (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
RekruttererFase 1/2
- Virginia Mason Medical Center, Seattle
- Fred Hutchinson Cancer Center, Seattle
- University of Washington Medical Center- Montlake, Seattle
GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC
RekruttererFase 1/2
- Fred Hutchinson Cancer Center, University of Washington, Seattle
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
Rekrutterer
- VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells
RekruttererFase 1
- Seattle Children's Hospital, Seattle
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, Seattle
Leverkreft-studier i andre byer
- Houston, TX14 studier
- Los Angeles, CA11 studier
- Cleveland, OH11 studier
- Dallas, TX10 studier
- Boston, MA9 studier
- Chicago, IL8 studier
- St. Louis, MO8 studier
- Durham, NC7 studier
- Philadelphia, PA7 studier
- Washington, DC6 studier
- San Francisco, CA6 studier
- Orange, CA6 studier
Andre studier i Seattle
- Ikke-småcellet lungekreft53 studier
- Kreft (alle typer)49 studier
- Prostatakreft42 studier
- Akut myelogen leukemi40 studier
- Brystkreft39 studier
- Metastatisk kreft39 studier
- Kolorektal kreft34 studier
- Lungekreft33 studier
- Eggstokkreft30 studier
- Multipelt myelom22 studier
- Myelodysplastiske syndromer21 studier
- Akut lymfoblastisk leukemi21 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.